Clinical Trials

Classical hematologyOther hematologic neoplasm

Anemia, Aplastic, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Metabolic Diseases, Hematologic Neoplasms

NCT04776941 2026-06-02

Expressive Writing for the Management of Stress in Cancer Survivors

414 enrolled

Hematologic Neoplasms

NCT07052370 2026-06-02

TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies

Phase NA Not yet recruiting

Hematologic Neoplasms

NCT07621887 2026-06-02

Digitalized Exercise Fit Tool Intervention for Adolescents With Blood Cancer

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Motor Activity, Neoplasms, Hematologic Neoplasms

NCT04552288 2026-06-01

Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

Phase 2 Completed

51 enrolled 8 charts

Hematologic Neoplasms

NCT06469307 2026-05-28

DIVERSE

40 enrolled

Leukemia, Hematologic Neoplasms

NCT07359859 2026-05-27

A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

40 enrolled

Graft vs Host Disease, Hematologic Neoplasms

NCT07052916 2026-05-26

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT07607379 2026-05-26

ROBDOG

Phase NA Not yet recruiting

28 enrolled

Hematologic Neoplasms

NCT01628029 2026-05-22

Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

68 enrolled 16 charts

Phase 4 Active not recruiting

Sleep Wake Disorders, Hematologic Neoplasms

NCT03023631 2026-05-20

Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

48 enrolled

Phase 1/2 Active not recruiting

Hematologic Neoplasms

NCT04565665 2026-05-20

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

65 enrolled

Phase NA Active not recruiting

COVID-19, Hematologic Neoplasms

NCT05102656 2026-05-20

Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic

107 enrolled

COVID-19, Hematologic Neoplasms

NCT07257419 2026-05-19

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

LymphoidOther hematologic neoplasm

70 enrolled

Recurrence, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07292272 2026-05-18

HALTAging-1

LymphoidOther hematologic neoplasmPlasma cell

180 enrolled

Hodgkin Disease, Leukemia, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Lymphoma, Non-Hodgkin, Multiple Myeloma, Hematologic Neoplasms

NCT02710253 2026-05-15

Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

230 enrolled

Neoplasm Metastasis, Hematologic Neoplasms

NCT06377059 2026-05-15

Early Detection of Complications During Immunotherapy for Haematological Malignancy

100 enrolled

Phase NA Active not recruiting

Cytokine Release Syndrome, Hematologic Neoplasms

NCT07251348 2026-05-15

Progressive Relaxation and Psychoeducation in Patients With Hematological Malignancies

75 enrolled

Phase 4 Not yet recruiting

Hematologic Neoplasms

NCT07590648 2026-05-15

E-STOP2

136 enrolled

Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

NCT05460013 2026-05-11

Impact of Oral Nutritional Supplements on Patients Undergoing Haematopoietic Stem Cell Transplantation

Phase NA Completed

100 enrolled 21 charts

Body Weight, Hematologic Neoplasms

NCT01451502 2026-05-08

Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

250 enrolled

Other hematologic neoplasmPlasma cell

Lymphatic Diseases, Hematologic Neoplasms

NCT03413800 2026-05-08

Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant

Phase 2 Completed

10 enrolled

Multiple Myeloma, Hematologic Neoplasms

NCT05256537 2026-05-07

OmitMMF

Hematologic Neoplasms

NCT05849207 2026-05-07

GeriBMT

26 enrolled

Hematologic Neoplasms

NCT05887167 2026-05-07

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

LymphoidOther hematologic neoplasmPlasma cell

20 enrolled

Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07043894 2026-05-07

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients

50 enrolled

Hematologic Neoplasms

NCT07413991 2026-05-07

Expressive Writing Program Among Young Adults With Blood Cancer

100 enrolled

Phase 1 Active not recruiting

Hematologic Neoplasms

NCT03560882 2026-05-06

A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies

50 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT04745910 2026-05-06

Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome

Phase 4 Completed

10 enrolled

Tumor Lysis Syndrome, Hematologic Neoplasms

NCT07570563 2026-05-06

Clinical Study of the Safety and Efficacy of QH101 Cell in Patients With Malignant Tumors.

Phase 1/2 Recruiting

24 enrolled

Phase EARLY_PHASE1 Recruiting

Hematologic Neoplasms

NCT04744116 2026-05-05

Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

24 enrolled

Hematologic Neoplasms

NCT05529069 2026-05-05

Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT03670966 2026-05-04

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Phase 1/2 Recruiting

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04509765 2026-05-04

A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT

Phase NA Completed

36 enrolled 13 charts

Hematologic Neoplasms

NCT04678427 2026-05-04

Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant

Hematologic Neoplasms

NCT02600208 2026-05-01

Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hematologic Neoplasms

NCT01231412 2026-04-30

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

Phase 3 Completed

174 enrolled 12 charts

Hodgkin Disease, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07172191 2026-04-30

HEMAT-FMT

Phase NA Enrolling by invitation

100 enrolled

Hematologic Neoplasms

NCT06807606 2026-04-28

Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation

35 enrolled

Hematologic Neoplasms

NCT05660421 2026-04-27

Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors

Phase 2 Withdrawn

Phase 3 Active not recruiting

Hematologic Neoplasms

NCT04829539 2026-04-24

BBT-II

400 enrolled

Phase NA Active not recruiting

Hematologic Neoplasms

NCT04888988 2026-04-24

CIPN

133 enrolled

Hematologic Neoplasms

NCT06676852 2026-04-24

Primary PC HCT

40 enrolled

Hematologic Neoplasms

NCT06532773 2026-04-23

Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment

Hematologic Neoplasms

NCT07133074 2026-04-22

RENEW-IN

3,800 enrolled

Hematologic Neoplasms

NCT01853358 2026-04-21

DLI-NK

Phase 1 Completed

17 enrolled